191 related articles for article (PubMed ID: 10554102)
21. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
23. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
Saad SY; Arafah MM; Najjar TA
Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
[TBL] [Abstract][Full Text] [Related]
24. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
[TBL] [Abstract][Full Text] [Related]
25. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
[TBL] [Abstract][Full Text] [Related]
26. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.
Domitrović R; Cvijanović O; Pugel EP; Zagorac GB; Mahmutefendić H; Škoda M
Toxicology; 2013 Aug; 310():115-23. PubMed ID: 23770416
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times.
Xu YY; Jiang N; Liu TS; Qu HQ; Wang T
Mol Med Rep; 2012 Nov; 6(5):1075-80. PubMed ID: 22895541
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558
[TBL] [Abstract][Full Text] [Related]
30. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
31. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
[TBL] [Abstract][Full Text] [Related]
32. Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity.
Pérez-Rojas JM; Cruz C; García-López P; Sánchez-González DJ; Martínez-Martínez CM; Ceballos G; Espinosa M; Meléndez-Zajgla J; Pedraza-Chaverri J
Free Radic Res; 2009; 43(11):1122-32. PubMed ID: 19863372
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin (CDDP)-induced acute toxicity in an experimental model of hepatic fibrosis.
Miyamoto Y; Shimada K; Sakaguchi Y; Miyamoto M
J Toxicol Sci; 2007 Aug; 32(3):311-9. PubMed ID: 17785946
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
35. L-methionine antagonism of cis-platinum nephrotoxicity.
Basinger MA; Jones MM; Holscher MA
Toxicol Appl Pharmacol; 1990 Mar; 103(1):1-15. PubMed ID: 2315922
[TBL] [Abstract][Full Text] [Related]
36. Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury.
Parlakpinar H; Sahna E; Ozer MK; Ozugurlu F; Vardi N; Acet A
J Pineal Res; 2002 Oct; 33(3):161-6. PubMed ID: 12220331
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system.
Nishiyama N; Kato Y; Sugiyama Y; Kataoka K
Pharm Res; 2001 Jul; 18(7):1035-41. PubMed ID: 11496942
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
[TBL] [Abstract][Full Text] [Related]
40. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
Smith MA; Smith JH; Litterst CL; Copley MP; Uozumi J; Boyd MR
Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]